NO20051287D0 - Aerosolformulering for inhalasjon som inneholder et anticholinergisk middel - Google Patents

Aerosolformulering for inhalasjon som inneholder et anticholinergisk middel

Info

Publication number
NO20051287D0
NO20051287D0 NO20051287A NO20051287A NO20051287D0 NO 20051287 D0 NO20051287 D0 NO 20051287D0 NO 20051287 A NO20051287 A NO 20051287A NO 20051287 A NO20051287 A NO 20051287A NO 20051287 D0 NO20051287 D0 NO 20051287D0
Authority
NO
Norway
Prior art keywords
inhalation
aerosol formulation
anticholinergic agent
aza
oxa
Prior art date
Application number
NO20051287A
Other languages
English (en)
Norwegian (no)
Other versions
NO20051287L (no
Inventor
Friedrich Schmidt
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=31979448&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20051287(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE10237232A external-priority patent/DE10237232A1/de
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of NO20051287L publication Critical patent/NO20051287L/no
Publication of NO20051287D0 publication Critical patent/NO20051287D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20051287A 2002-08-14 2005-03-11 Aerosolformulering for inhalasjon som inneholder et anticholinergisk middel NO20051287D0 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10237232A DE10237232A1 (de) 2002-08-14 2002-08-14 Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
DE10240257 2002-08-31
PCT/EP2003/008221 WO2004022052A1 (de) 2002-08-14 2003-07-25 Aerosolformulierung für die inhalation enthaltend ein anticholinergikum

Publications (2)

Publication Number Publication Date
NO20051287L NO20051287L (no) 2005-03-11
NO20051287D0 true NO20051287D0 (no) 2005-03-11

Family

ID=31979448

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20051287A NO20051287D0 (no) 2002-08-14 2005-03-11 Aerosolformulering for inhalasjon som inneholder et anticholinergisk middel

Country Status (31)

Country Link
EP (2) EP1908468A1 (sr)
JP (1) JP4602767B2 (sr)
KR (1) KR101060972B1 (sr)
CN (1) CN1674887A (sr)
AT (1) ATE400265T1 (sr)
AU (1) AU2003298473B9 (sr)
BR (1) BR0313457A (sr)
CA (1) CA2495275C (sr)
CY (1) CY1108776T1 (sr)
DE (1) DE50310117D1 (sr)
DK (1) DK1530464T3 (sr)
EA (1) EA009936B1 (sr)
EC (1) ECSP055600A (sr)
ES (1) ES2305479T3 (sr)
HR (1) HRP20050132A2 (sr)
IL (1) IL166814A (sr)
MX (1) MXPA05001595A (sr)
MY (1) MY142579A (sr)
NO (1) NO20051287D0 (sr)
NZ (1) NZ538743A (sr)
PE (1) PE20040372A1 (sr)
PL (1) PL375511A1 (sr)
PT (1) PT1530464E (sr)
RS (1) RS51396B (sr)
SA (1) SA03240265B1 (sr)
SI (1) SI1530464T1 (sr)
TW (1) TWI317279B (sr)
UA (1) UA81775C2 (sr)
UY (1) UY27938A1 (sr)
WO (1) WO2004022052A1 (sr)
ZA (1) ZA200410325B (sr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004038885A1 (de) * 2004-08-10 2006-02-23 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
DE102005001297A1 (de) * 2005-01-12 2006-07-20 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
DE102005055960A1 (de) * 2005-11-24 2007-07-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
DE102005055958A1 (de) * 2005-11-24 2007-07-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
DE102005055963A1 (de) * 2005-11-24 2007-07-19 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
DE102005055957A1 (de) * 2005-11-24 2007-07-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
EP2414560B1 (de) 2009-03-31 2013-10-23 Boehringer Ingelheim International GmbH Verfahren zur beschichtung einer oberfläche eines bauteils
EP3508239B1 (de) 2009-05-18 2020-12-23 Boehringer Ingelheim International GmbH Adapter, inhalationseinrichtung und zerstäuber
MX2012005961A (es) 2009-11-25 2012-06-14 Boehringer Ingelheim Int Nebulizador.
JP5658268B2 (ja) 2009-11-25 2015-01-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
JP5874724B2 (ja) 2010-06-24 2016-03-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
WO2012130757A1 (de) 2011-04-01 2012-10-04 Boehringer Ingelheim International Gmbh Medizinisches gerät mit behälter
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
WO2015018904A1 (en) 2013-08-09 2015-02-12 Boehringer Ingelheim International Gmbh Nebulizer
EP2835146B1 (en) 2013-08-09 2020-09-30 Boehringer Ingelheim International GmbH Nebulizer
LT3099172T (lt) 2014-01-31 2021-12-27 AgBiome, Inc. Modifikuotas biologinės kontrolės agentas ir jo naudojimas
US9877486B2 (en) 2014-01-31 2018-01-30 AgBiome, Inc. Methods of growing plants using modified biological control agents
WO2015169430A1 (en) 2014-05-07 2015-11-12 Boehringer Ingelheim International Gmbh Nebulizer
BR122022010094B1 (pt) 2014-05-07 2023-10-03 Boehringer Ingelheim International Gmbh Dispositivo indicador e recipiente
MX383195B (es) 2014-05-07 2025-03-13 Boehringer Ingelheim Int Recipiente, nebulizador y uso.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG45171A1 (en) * 1990-03-21 1998-01-16 Boehringer Ingelheim Int Atomising devices and methods
DE19653969A1 (de) * 1996-12-20 1998-06-25 Boehringer Ingelheim Kg Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
JP5392880B2 (ja) * 2000-05-22 2014-01-22 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ 加圧式定量吸入器のための安定な製薬学的溶液製剤
DE10050994A1 (de) * 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung
DE10063957A1 (de) * 2000-12-20 2002-06-27 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Dopamin-Agonisten
DE10200943A1 (de) * 2002-01-12 2003-07-24 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Scopinestern

Also Published As

Publication number Publication date
JP4602767B2 (ja) 2010-12-22
AU2003298473B2 (en) 2009-04-23
EP1530464B1 (de) 2008-07-09
AU2003298473B9 (en) 2011-06-09
EP1908468A1 (de) 2008-04-09
ECSP055600A (es) 2005-04-18
JP2006506345A (ja) 2006-02-23
AU2003298473A1 (en) 2004-03-29
TW200406213A (en) 2004-05-01
RS20050074A (sr) 2007-09-21
CY1108776T1 (el) 2014-04-09
NZ538743A (en) 2006-05-26
ES2305479T3 (es) 2008-11-01
NO20051287L (no) 2005-03-11
UY27938A1 (es) 2004-03-31
PL375511A1 (en) 2005-11-28
EP1530464A1 (de) 2005-05-18
IL166814A0 (en) 2006-01-15
MXPA05001595A (es) 2005-04-25
WO2004022052A1 (de) 2004-03-18
BR0313457A (pt) 2005-06-21
CA2495275C (en) 2012-04-17
EA009936B1 (ru) 2008-04-28
TWI317279B (en) 2009-11-21
ZA200410325B (en) 2006-10-25
RS51396B (sr) 2011-02-28
EA200500292A1 (ru) 2005-10-27
UA81775C2 (uk) 2008-02-11
HRP20050132A2 (en) 2006-05-31
DE50310117D1 (de) 2008-08-21
KR20050049478A (ko) 2005-05-25
PE20040372A1 (es) 2004-08-03
CA2495275A1 (en) 2004-03-18
SA03240265B1 (ar) 2009-11-10
SI1530464T1 (sl) 2008-12-31
IL166814A (en) 2010-11-30
CN1674887A (zh) 2005-09-28
MY142579A (en) 2010-12-15
ATE400265T1 (de) 2008-07-15
KR101060972B1 (ko) 2011-09-01
PT1530464E (pt) 2008-08-28
DK1530464T3 (da) 2008-09-08

Similar Documents

Publication Publication Date Title
CY1108776T1 (el) Σκευασμα αερολυματος για εισπνοη που περιεχει αντιχολινεργικο
HRP20080140T3 (en) Aerosol formulation for inhalation, containing an anticholinergic agent
CO5540380A2 (es) Medicamentos inhalativos que contienen un nuevo anticolinergico en combinacion con corticosteroides y betamimeticos
RU2361593C3 (ru) Комбинация азеластина и стероидов
AR039404A1 (es) Combinaciones de medicamentos que contienen compuestos heterociclicos y un agente anticolinergico. aerosol para su inhalacion
JP2006506345A5 (sr)
WO2007060108A3 (de) Aerosolformulierung für die inhalation enthaltend ein anticholinergikum
WO2007060104A3 (de) Aerosolformulierung für die inhalation enthaltend ein anticholinergikum
SE0002476D0 (sv) New compounds
EP2253312A3 (de) Verwendung von aus extremophilen Bakterien gewonnenen Osmolyten zur Herstellung von inhalierbaren Arzneimittel zur Prophylaxe und Behandlung pulmonaler und kardiovaskulärer Erkrankungen, sowie eine Osmolyte als Wirkstoffbestandteil enthaltende Inhalationsvorrichtung
NO20044001L (no) Aerosolformulering for inhalasjon omfattende et tiotropiumsalt
NO337768B1 (no) Væskeformig, farmasøytisk preparat av piperazinderivater, og minst ett konserveringsmiddel av parahydroksybenzoatestere
PL374022A1 (en) Novel drug compositions based on novel anticholinergics and inhibitors of egfr-kinase
WO2002036104A3 (de) Inhalative lösungsformulierung mit einem tiotropiumsalz
AR039634A1 (es) Medicamento que contiene betamimeticos y un anticolinergico
AR040864A1 (es) Formulacion aerosol para inhalacion, que contiene un agente anticolinergico
TH78671A (th) สูตรผสมแอโรซอลสำหรับการสูดดม ซึ่งประกอบรวมด้วยแอนติโคลิเนอร์จิก
TH75872A (th) สูตรผสมชนิดแอโรซอลสำหรับการสูดดมเบต้า-อะโกนิสต์

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application